Canadian health ministry is given new powers to tighten drug safetyBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g4231 (Published 24 June 2014) Cite this as: BMJ 2014;348:g4231
- Owen Dyer
Canada’s House of Commons has granted the health ministry sweeping new powers to remove drugs from the market and punish manufacturers who sell dangerous drugs or withhold information on adverse effects.
Until now, the Canadian government has relied on voluntary agreements with manufacturers to remove dangerous medicines from the market, a system that broke down most notoriously in 1962 when a special act of parliament was needed to remove thalidomide from the Canadian market long after the US Food and Drug Administration had refused approval and European nations had banned the drug. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial